143 related articles for article (PubMed ID: 18443366)
1. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D
FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366
[TBL] [Abstract][Full Text] [Related]
2. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
3. The AP-2alpha transcription factor regulates tumor cell migration and apoptosis.
Orso F; Fassetta M; Penna E; Solero A; De Filippo K; Sismondi P; De Bortoli M; Taverna D
Adv Exp Med Biol; 2007; 604():87-95. PubMed ID: 17695722
[TBL] [Abstract][Full Text] [Related]
4. Modulation of IFN-γ receptor 1 expression by AP-2α influences IFN-γ sensitivity of cancer cells.
Chen C; Guo L; Shi M; Hu M; Hu M; Yu M; Wang T; Song L; Shen B; Qian L; Guo N
Am J Pathol; 2012 Feb; 180(2):661-71. PubMed ID: 22182699
[TBL] [Abstract][Full Text] [Related]
5. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy.
Wajapeyee N; Raut CG; Somasundaram K
Cancer Res; 2005 Oct; 65(19):8628-34. PubMed ID: 16204029
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
Gee JM; Eloranta JJ; Ibbitt JC; Robertson JF; Ellis IO; Williams T; Nicholson RI; Hurst HC
J Pathol; 2009 Jan; 217(1):32-41. PubMed ID: 18825690
[TBL] [Abstract][Full Text] [Related]
7. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
8. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
[TBL] [Abstract][Full Text] [Related]
9. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
10. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
11. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
12. Involvement of transcription factor activator protein-2alpha in doxazosin-induced HeLa cell apoptosis.
Gan L; Zhu DX; Yang LP; Liu RS; Yan F; Zhang J
Acta Pharmacol Sin; 2008 Apr; 29(4):465-72. PubMed ID: 18358093
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
15. AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.
Li H; Watts GS; Oshiro MM; Futscher BW; Domann FE
Oncogene; 2006 Aug; 25(39):5405-15. PubMed ID: 16636674
[TBL] [Abstract][Full Text] [Related]
16. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
18. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
[TBL] [Abstract][Full Text] [Related]
19. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
20. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
Visser S; Yang X
Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]